Quantbot Technologies’s Vaxcyte PCVX Stock Holding History

Quantbot Technologies’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$21K	Buy	+361	New	+$19.6K	﹤0.01%	1775
2026 Q1	–	Sell	-5,399	Closed	-$249K	–	2048
2025 Q4	$249K	Buy	+5,399	New	+$241K	0.01%	1176
2025 Q3	–	Sell	-6,821	Closed	-$222K	–	2023
2025 Q2	$222K	Buy	+6,821	New	+$224K	0.01%	1208
2024 Q2	–	Sell	-57	Closed	-$3.89K	–	1800
2024 Q1	$3.89K	Buy	+57	New	+$3.95K	﹤0.01%	1487
2023 Q1	–	Sell	-22,100	Closed	-$1.06M	–	1936
2022 Q4	$1.06M	Buy	+22,100	New	+$867K	0.08%	364
2022 Q1	–	Sell	-1,800	Closed	-$42K	–	1956
2021 Q4	$42K	Sell	1,800 -1,500	-45%	-$34.9K	﹤0.01%	1070
2021 Q3	$83K	Buy	3,300 +1,800	+120%	+$43.6K	0.01%	1009
2021 Q2	$33K	Buy	+1,500	New	+$30.7K	﹤0.01%	1148

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Quantbot Technologies's PCVX Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Vaxcyte (PCVX) in Q2 2026: 361 shares worth $21K. The stake represents ﹤0.01% of the portfolio and ranks #1775 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in PCVX as recently as Q4 2025.

Quantbot Technologies first reported a position in PCVX in Q2 2021 and has held it in 8 quarters since. The position peaked at $1.06M in Q4 2022. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Quantbot Technologies held 361 shares of Vaxcyte worth $21K as of Q2 2026.
Vaxcyte was a new Quantbot Technologies position in Q2 2026.
Vaxcyte made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1775 holding.
Quantbot Technologies first reported a position in Vaxcyte in Q2 2021 and has held it in 8 quarters since.
Quantbot Technologies's Vaxcyte position peaked at $1.06M in Q4 2022.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.